FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target and destroy tissue without delivering excess heat and the uni | AngioDynamics obtained a green light for its NanoKnife prostate cancer ablation system,
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for prostate tissue ablation. The clearance for the NanoKnife System for prostate tissue ablation follows the completion of the pivotal PRESERVE clinical study and submission of results to the FDA in September.
AngioDynamics wins FDA clearance for NanoKnife system in prostate tissue ablation
AngioDynamics received FDA 510(k) clearance for its NanoKnife system for prostate tissue ablation in intermediate-risk prostate cancer.
NanoKnife gains FDA clearance for prostate tissue ablation
AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ablation of soft tissue, is now indicated for prostate tissue ablation.
AngioDynamics Receives FDA Clearance for NanoKnife System, Poised for Growth with New Market Opportunities and Clinical Success
Canaccord Genuity analyst John Young CFA has maintained their bullish stance on ANGO stock, giving a Buy rating today.Pick the best stocks and
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife
Shares of AngioDynamics hit a 52-week high after the company's NanoKnife System for prostate tissue ablation received regulatory clearance. The stock jumped almost 35% to a high of $9.42 in early trading. Shares are now in positive territory year-to-date.
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment ...
AngioDynamics receives FDA 510(k) clearance for NanoKnife System
AngioDynamics (ANGO) announced it received U.S. FDA 510(k) clearance for the NanoKnife System for prostate tissue ablation. Pick the best
Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?
AngioDynamics (ANGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...
Hosted on MSN15h
Baxter Stock May Gain Following Five New Injectable Product Launches
Baxter International BAX recently announced the launch of five new injectable pharmaceutical products in the United States, ...
36,649 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Acquired by Quest Partners LLC
Quest Partners LLC acquired a new stake in AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) in the 3rd quarter, according to ...
CNN11mon
AngioDynamics, Inc.
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology.